 Ellen Elias
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smith-Lemli-Opitz Syndrome | 15 | 2017 | 17 | 1.400 |
Why?
| | Disabled Children | 5 | 2021 | 69 | 0.960 |
Why?
| | Neurodevelopmental Disorders | 3 | 2024 | 151 | 0.880 |
Why?
| | Cholesterol | 15 | 2010 | 399 | 0.640 |
Why?
| | Health Services Needs and Demand | 3 | 2017 | 262 | 0.620 |
Why?
| | Nuclear Proteins | 2 | 2020 | 644 | 0.590 |
Why?
| | Transitional Care | 1 | 2017 | 39 | 0.530 |
Why?
| | Carrier Proteins | 1 | 2019 | 730 | 0.490 |
Why?
| | Phenotype | 6 | 2019 | 3063 | 0.480 |
Why?
| | Developmental Disabilities | 4 | 2021 | 255 | 0.480 |
Why?
| | Autism Spectrum Disorder | 5 | 2021 | 375 | 0.480 |
Why?
| | Mutation | 6 | 2024 | 3674 | 0.480 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 321 | 0.470 |
Why?
| | Abnormalities, Multiple | 12 | 2018 | 180 | 0.460 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 7 | 2017 | 23 | 0.430 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2012 | 10 | 0.400 |
Why?
| | Self-Help Devices | 1 | 2012 | 19 | 0.390 |
Why?
| | Equipment and Supplies | 1 | 2012 | 41 | 0.390 |
Why?
| | Health Services Accessibility | 2 | 2017 | 908 | 0.390 |
Why?
| | Interdisciplinary Communication | 2 | 2014 | 189 | 0.390 |
Why?
| | Facies | 4 | 2020 | 21 | 0.380 |
Why?
| | Cooperative Behavior | 2 | 2014 | 429 | 0.340 |
Why?
| | Autistic Disorder | 2 | 2010 | 184 | 0.340 |
Why?
| | Child | 35 | 2024 | 20963 | 0.330 |
Why?
| | Child, Preschool | 28 | 2024 | 10565 | 0.320 |
Why?
| | Megalencephaly | 2 | 2024 | 19 | 0.320 |
Why?
| | Craniofacial Abnormalities | 2 | 2019 | 62 | 0.320 |
Why?
| | Psychosexual Development | 1 | 2006 | 3 | 0.270 |
Why?
| | Sexuality | 1 | 2006 | 20 | 0.260 |
Why?
| | Infant | 24 | 2024 | 9097 | 0.260 |
Why?
| | Limb Deformities, Congenital | 2 | 2024 | 11 | 0.260 |
Why?
| | Chronic Disease | 1 | 2012 | 1721 | 0.250 |
Why?
| | Intellectual Disability | 4 | 2020 | 153 | 0.250 |
Why?
| | Oxidoreductases | 6 | 2000 | 91 | 0.240 |
Why?
| | Acro-Osteolysis | 1 | 2024 | 2 | 0.240 |
Why?
| | Progeria | 1 | 2024 | 5 | 0.230 |
Why?
| | Dehydrocholesterols | 7 | 2012 | 7 | 0.230 |
Why?
| | Adolescent | 25 | 2024 | 20355 | 0.230 |
Why?
| | RNA, Small Nuclear | 1 | 2024 | 35 | 0.230 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2003 | 13 | 0.220 |
Why?
| | Vision, Ocular | 1 | 2003 | 32 | 0.220 |
Why?
| | Dwarfism | 1 | 2023 | 15 | 0.210 |
Why?
| | Infant, Newborn | 15 | 2018 | 5752 | 0.210 |
Why?
| | Osteochondrodysplasias | 1 | 2023 | 15 | 0.210 |
Why?
| | Retinal Diseases | 1 | 2003 | 86 | 0.210 |
Why?
| | Face | 4 | 2020 | 168 | 0.200 |
Why?
| | Syndrome | 10 | 2024 | 343 | 0.200 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2020 | 3 | 0.180 |
Why?
| | Genetic Association Studies | 2 | 2019 | 356 | 0.180 |
Why?
| | Sexual Health | 1 | 2021 | 56 | 0.170 |
Why?
| | Humans | 48 | 2024 | 129705 | 0.170 |
Why?
| | Mutation, Missense | 2 | 2020 | 319 | 0.160 |
Why?
| | Female | 38 | 2024 | 68561 | 0.150 |
Why?
| | Cerebellum | 1 | 1999 | 216 | 0.140 |
Why?
| | Electroretinography | 2 | 2010 | 44 | 0.140 |
Why?
| | Repressor Proteins | 1 | 2020 | 400 | 0.130 |
Why?
| | Premature Birth | 1 | 2020 | 313 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 559 | 0.130 |
Why?
| | Heart Defects, Congenital | 3 | 1999 | 754 | 0.130 |
Why?
| | Communication Barriers | 1 | 2017 | 102 | 0.130 |
Why?
| | Metabolism, Inborn Errors | 1 | 1995 | 40 | 0.120 |
Why?
| | Male | 26 | 2024 | 63544 | 0.120 |
Why?
| | Child Nutrition Disorders | 1 | 2014 | 17 | 0.120 |
Why?
| | Brain | 3 | 2024 | 2596 | 0.120 |
Why?
| | Heterozygote | 3 | 2024 | 268 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 2 | 2020 | 2272 | 0.110 |
Why?
| | Puberty, Precocious | 1 | 1994 | 14 | 0.110 |
Why?
| | Malnutrition | 1 | 2014 | 79 | 0.110 |
Why?
| | Child Abuse, Sexual | 2 | 2021 | 90 | 0.110 |
Why?
| | Meningomyelocele | 1 | 1994 | 59 | 0.110 |
Why?
| | Cognition | 2 | 2020 | 1098 | 0.110 |
Why?
| | Contraception Behavior | 2 | 2021 | 94 | 0.110 |
Why?
| | Enteral Nutrition | 1 | 2014 | 190 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 329 | 0.100 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 94 | 0.100 |
Why?
| | Physician's Role | 2 | 2021 | 202 | 0.100 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2012 | 101 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1423 | 0.090 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2010 | 14 | 0.090 |
Why?
| | Transcription Factors | 1 | 2018 | 1636 | 0.090 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2010 | 15 | 0.090 |
Why?
| | Down Syndrome | 1 | 2016 | 455 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2010 | 148 | 0.080 |
Why?
| | Neurocutaneous Syndromes | 1 | 2009 | 3 | 0.080 |
Why?
| | Angelman Syndrome | 1 | 2009 | 11 | 0.080 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2009 | 25 | 0.080 |
Why?
| | Rett Syndrome | 1 | 2009 | 35 | 0.080 |
Why?
| | Growth Disorders | 3 | 1999 | 79 | 0.070 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 73 | 0.070 |
Why?
| | Bile Acids and Salts | 4 | 1997 | 197 | 0.070 |
Why?
| | Internship and Residency | 1 | 2017 | 1056 | 0.070 |
Why?
| | Patient-Centered Care | 1 | 2012 | 505 | 0.070 |
Why?
| | Thyroid Neoplasms | 1 | 2010 | 308 | 0.070 |
Why?
| | Patient Readmission | 1 | 2012 | 675 | 0.070 |
Why?
| | Chromosome Deletion | 2 | 1997 | 104 | 0.070 |
Why?
| | Sex Education | 1 | 2006 | 34 | 0.070 |
Why?
| | Beckwith-Wiedemann Syndrome | 2 | 1999 | 7 | 0.060 |
Why?
| | Child, Exceptional | 1 | 2005 | 2 | 0.060 |
Why?
| | Patient Discharge | 1 | 2012 | 862 | 0.060 |
Why?
| | Pregnancy | 5 | 2021 | 6273 | 0.060 |
Why?
| | Aortic Stenosis, Subvalvular | 1 | 2005 | 4 | 0.060 |
Why?
| | Adult | 13 | 2018 | 35595 | 0.060 |
Why?
| | Marfan Syndrome | 1 | 2005 | 42 | 0.060 |
Why?
| | Craniosynostoses | 1 | 2005 | 34 | 0.060 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 1995 | 17 | 0.060 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2005 | 84 | 0.060 |
Why?
| | Self Concept | 1 | 2006 | 237 | 0.060 |
Why?
| | RNA Splice Sites | 1 | 2024 | 40 | 0.060 |
Why?
| | Tetralogy of Fallot | 1 | 2005 | 79 | 0.060 |
Why?
| | Spliceosomes | 1 | 2024 | 40 | 0.060 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2003 | 12 | 0.060 |
Why?
| | Alleles | 2 | 2024 | 849 | 0.050 |
Why?
| | Glypicans | 1 | 2023 | 9 | 0.050 |
Why?
| | Rare Diseases | 1 | 2024 | 102 | 0.050 |
Why?
| | Sterols | 4 | 1997 | 18 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2006 | 254 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2005 | 4939 | 0.050 |
Why?
| | Interpersonal Relations | 1 | 2006 | 390 | 0.050 |
Why?
| | Genetic Variation | 2 | 2018 | 936 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 220 | 0.050 |
Why?
| | Hand Deformities, Congenital | 2 | 2018 | 8 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 187 | 0.050 |
Why?
| | Cholestadienols | 2 | 1998 | 2 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2003 | 510 | 0.050 |
Why?
| | Young Adult | 4 | 2024 | 12363 | 0.050 |
Why?
| | Menstruation | 1 | 2021 | 43 | 0.050 |
Why?
| | Genetic Counseling | 1 | 2021 | 72 | 0.040 |
Why?
| | Genetic Techniques | 1 | 2020 | 64 | 0.040 |
Why?
| | Spinal Dysraphism | 1 | 2021 | 66 | 0.040 |
Why?
| | Kinetics | 1 | 2003 | 1620 | 0.040 |
Why?
| | Puberty | 1 | 2021 | 143 | 0.040 |
Why?
| | Dandy-Walker Syndrome | 1 | 1999 | 7 | 0.040 |
Why?
| | Cholesterol, Dietary | 2 | 1997 | 18 | 0.040 |
Why?
| | Pediatricians | 1 | 2021 | 133 | 0.040 |
Why?
| | Growth Hormone | 1 | 1999 | 96 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2024 | 819 | 0.040 |
Why?
| | Sexually Transmitted Diseases | 1 | 2021 | 172 | 0.040 |
Why?
| | Patient Transfer | 1 | 2021 | 164 | 0.040 |
Why?
| | Skull | 1 | 2020 | 128 | 0.040 |
Why?
| | Penetrance | 1 | 2018 | 27 | 0.040 |
Why?
| | Caregivers | 1 | 2006 | 831 | 0.040 |
Why?
| | Micrognathism | 1 | 2018 | 16 | 0.040 |
Why?
| | Amniocentesis | 1 | 1998 | 23 | 0.040 |
Why?
| | Larynx | 1 | 1999 | 54 | 0.040 |
Why?
| | Chromosome Breakage | 1 | 1998 | 21 | 0.040 |
Why?
| | Fanconi Anemia | 1 | 1998 | 10 | 0.040 |
Why?
| | Homozygote | 2 | 1995 | 192 | 0.040 |
Why?
| | Neck | 1 | 2018 | 92 | 0.040 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2018 | 111 | 0.040 |
Why?
| | Pediatrics | 1 | 2006 | 1071 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 1998 | 79 | 0.040 |
Why?
| | Spinal Cord Injuries | 1 | 2021 | 190 | 0.040 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 1997 | 41 | 0.040 |
Why?
| | Exome | 1 | 2018 | 219 | 0.040 |
Why?
| | Hirschsprung Disease | 1 | 1999 | 98 | 0.040 |
Why?
| | Intelligence Tests | 1 | 2017 | 59 | 0.030 |
Why?
| | Endocrine Glands | 1 | 1997 | 15 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2021 | 483 | 0.030 |
Why?
| | Growth | 1 | 1997 | 57 | 0.030 |
Why?
| | Piperazines | 2 | 1997 | 327 | 0.030 |
Why?
| | Microcephaly | 2 | 1994 | 57 | 0.030 |
Why?
| | Behavior | 1 | 1997 | 92 | 0.030 |
Why?
| | Fetal Death | 1 | 1996 | 55 | 0.030 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1996 | 55 | 0.030 |
Why?
| | Genotype | 2 | 2017 | 1836 | 0.030 |
Why?
| | Microsomes, Liver | 1 | 1995 | 64 | 0.030 |
Why?
| | Enzyme Inhibitors | 2 | 1997 | 828 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 1995 | 39 | 0.030 |
Why?
| | Mosaicism | 1 | 1996 | 71 | 0.030 |
Why?
| | Trisomy | 1 | 1996 | 75 | 0.030 |
Why?
| | Skin Diseases | 1 | 1997 | 144 | 0.030 |
Why?
| | Kidney Diseases | 1 | 1999 | 367 | 0.030 |
Why?
| | United States | 1 | 2012 | 14078 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 1997 | 199 | 0.030 |
Why?
| | Bone and Bones | 1 | 1997 | 297 | 0.030 |
Why?
| | Primary Health Care | 1 | 2005 | 1668 | 0.030 |
Why?
| | Nutritional Requirements | 1 | 2014 | 76 | 0.030 |
Why?
| | Child Development | 1 | 2019 | 452 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 31103 | 0.030 |
Why?
| | Cataract | 1 | 1997 | 197 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 2778 | 0.030 |
Why?
| | Anticholesteremic Agents | 1 | 1995 | 145 | 0.030 |
Why?
| | Menarche | 1 | 1994 | 58 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 863 | 0.030 |
Why?
| | Professional-Family Relations | 1 | 2014 | 144 | 0.030 |
Why?
| | Hydrocephalus | 1 | 1994 | 104 | 0.030 |
Why?
| | Blood Specimen Collection | 1 | 2012 | 33 | 0.030 |
Why?
| | Animals | 4 | 2020 | 34733 | 0.030 |
Why?
| | Esters | 1 | 2012 | 74 | 0.020 |
Why?
| | Adrenal Cortex Diseases | 1 | 1991 | 1 | 0.020 |
Why?
| | Oxyphil Cells | 1 | 2010 | 2 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2012 | 484 | 0.020 |
Why?
| | Cysts | 1 | 1991 | 108 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2314 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 441 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2010 | 88 | 0.020 |
Why?
| | Severity of Illness Index | 3 | 2005 | 2783 | 0.020 |
Why?
| | Incidence | 1 | 1996 | 2658 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2012 | 1013 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 842 | 0.020 |
Why?
| | Rats | 1 | 1995 | 5244 | 0.020 |
Why?
| | Economics, Medical | 1 | 2005 | 4 | 0.020 |
Why?
| | Hospital Departments | 1 | 2005 | 9 | 0.020 |
Why?
| | Comorbidity | 1 | 2010 | 1545 | 0.020 |
Why?
| | Laboratories, Hospital | 1 | 2005 | 14 | 0.020 |
Why?
| | Health Maintenance Organizations | 1 | 2005 | 98 | 0.020 |
Why?
| | Polymorphism, Genetic | 2 | 2000 | 643 | 0.010 |
Why?
| | Hospital Costs | 1 | 2005 | 117 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2005 | 211 | 0.010 |
Why?
| | Specialization | 1 | 2005 | 145 | 0.010 |
Why?
| | Health Resources | 1 | 2005 | 124 | 0.010 |
Why?
| | Mice | 1 | 2020 | 16585 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 2003 | 127 | 0.010 |
Why?
| | Hydrogen | 1 | 2003 | 64 | 0.010 |
Why?
| | Health Expenditures | 1 | 2005 | 187 | 0.010 |
Why?
| | Quality of Life | 1 | 2014 | 2712 | 0.010 |
Why?
| | Needs Assessment | 1 | 2005 | 363 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2003 | 14669 | 0.010 |
Why?
| | Echocardiography | 1 | 2005 | 635 | 0.010 |
Why?
| | Outpatients | 1 | 2005 | 366 | 0.010 |
Why?
| | Hospitals, Pediatric | 1 | 2005 | 519 | 0.010 |
Why?
| | Inpatients | 1 | 2005 | 456 | 0.010 |
Why?
| | Cardiac Catheterization | 1 | 2005 | 583 | 0.010 |
Why?
| | Medicaid | 1 | 2005 | 447 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2000 | 69 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 2 | 2003 | 3351 | 0.010 |
Why?
| | Polydactyly | 1 | 1999 | 6 | 0.010 |
Why?
| | Cytogenetic Analysis | 1 | 1999 | 34 | 0.010 |
Why?
| | Karyotyping | 1 | 1999 | 107 | 0.010 |
Why?
| | Exons | 1 | 2000 | 330 | 0.010 |
Why?
| | Nuclear Family | 1 | 1999 | 50 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2000 | 391 | 0.010 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 1998 | 128 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 1999 | 319 | 0.010 |
Why?
| | Ribs | 1 | 1997 | 33 | 0.010 |
Why?
| | Models, Genetic | 1 | 2000 | 586 | 0.010 |
Why?
| | Arm | 1 | 1997 | 107 | 0.010 |
Why?
| | Reference Values | 1 | 1998 | 792 | 0.010 |
Why?
| | Spine | 1 | 1997 | 155 | 0.010 |
Why?
| | Pregnancy Outcome | 1 | 1998 | 379 | 0.010 |
Why?
| | Leg | 1 | 1997 | 241 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1997 | 259 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 97 | 0.010 |
Why?
| | Hospitalization | 1 | 2005 | 2091 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2005 | 2539 | 0.010 |
Why?
| | Gestational Age | 1 | 1998 | 857 | 0.010 |
Why?
| | Colorado | 1 | 2005 | 4471 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 5410 | 0.010 |
Why?
| | Ursodeoxycholic Acid | 1 | 1994 | 21 | 0.010 |
Why?
| | Ultrasonography | 1 | 1998 | 729 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1994 | 75 | 0.010 |
Why?
| | Failure to Thrive | 1 | 1994 | 31 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1997 | 1024 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 1047 | 0.010 |
Why?
| | Fetal Growth Retardation | 1 | 1998 | 542 | 0.010 |
Why?
| | Hypertrophy | 1 | 1991 | 120 | 0.010 |
Why?
| | Feces | 1 | 1994 | 434 | 0.010 |
Why?
| | Prenatal Diagnosis | 1 | 1991 | 191 | 0.010 |
Why?
| | Ultrasonography, Prenatal | 1 | 1991 | 268 | 0.010 |
Why?
| | Erythrocytes | 1 | 1994 | 668 | 0.000 |
Why?
| | Liver | 1 | 1997 | 1848 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1997 | 4016 | 0.000 |
Why?
|
|
Elias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|